Package 63304-506-01

{"route": ["ORAL"], "spl_id": "48ee2bd7-f7c9-4bf8-8932-ba9065c64cf3", "openfda": {"nui": ["N0000175686", "N0000175688", "N0000175685"], "upc": ["0363304506013"], "unii": ["F850569PQR", "RP4A60D26L"], "rxcui": ["312289"], "spl_set_id": ["41ebdaaf-3bbc-419f-b996-0341efc14623"], "pharm_class_epc": ["Partial Opioid Agonist/Antagonist [EPC]"], "pharm_class_moa": ["Competitive Opioid Antagonists [MoA]", "Partial Opioid Agonists [MoA]"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (63304-506-01)", "package_ndc": "63304-506-01", "marketing_start_date": "20180731"}], "brand_name": "pentazocine and naloxone", "product_id": "63304-506_48ee2bd7-f7c9-4bf8-8932-ba9065c64cf3", "dosage_form": "TABLET", "pharm_class": ["Competitive Opioid Antagonists [MoA]", "Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]", "Partial Opioid Agonist/Antagonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "63304-506", "dea_schedule": "CIV", "generic_name": "pentazocine and naloxone", "labeler_name": "Sun Pharmaceutical Industries, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "pentazocine and naloxone", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": ".5 mg/1"}, {"name": "PENTAZOCINE", "strength": "50 mg/1"}], "application_number": "ANDA075523", "marketing_category": "ANDA", "marketing_start_date": "20180731", "listing_expiration_date": "20261231"}